|
1
|
Min A, Zhu C, Peng S, Rajthala S, Costea
DE and Sapkota D: MicroRNAs as important players and biomarkers in
oral carcinogenesis. Biomed Res Int. 2015:1869042015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Warnakulasuriya S: Global epidemiology of
oral and oropharyngeal cancer. Oral Oncol. 45:309–316. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Zaravinos A: An updated overview of
HPV-associated head and neck carcinomas. Oncotarget. 5:3956–3969.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Leemans CR, Braakhuis BJ and Brakenhoff
RH: The molecular biology of head and neck cancer. Nat Rev Cancer.
11:9–22. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
5
|
Perez-Sayans M, Suarez-Penaranda JM,
Padin-Iruegas ME, Gayoso-Diz P, Reis-De Almeida M, Barros-Angueira
F, Gandara-Vila P, Blanco-Carrion A and Garcia-Garcia A: The loss
of p16 expression worsens the prognosis of OSCC. Appl
Immunohistochem Mol Morphol. 23:724–732. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Liang L, Zhang T, Kong Q, Liang J and Liao
G: A meta-analysis on selective versus comprehensive neck
dissection in oral squamous cell carcinoma patients with clinically
node-positive neck. Oral Oncol. 51:1076–1081. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Moreno-Moya JM, Vilella F and Simon C:
MicroRNA: Key gene expression regulators. Fertil Steril.
101:1516–1523. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
John B, Enright AJ, Aravin A, Tuschl T,
Sander C and Marks DS: Human MicroRNA targets. PLoS Biol.
2:e3632004. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Vasudevan S, Tong Y and Steitz JA:
Switching from repression to activation: microRNAs can up-regulate
translation. Science. 318:1931–1934. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Calin GA and Croce CM: MicroRNA signatures
in human cancers. Nat Rev Cancer. 6:857–866. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wang YJ, Zhang ZF, Fan SH, Zhuang J, Shan
Q, Han XR, Wen X, Li MQ, Hu B, Sun CH, et al: MicroRNA-433 inhibits
oral squamous cell carcinoma cells by targeting FAK. Oncotarget.
8:100227–100241. 2017.PubMed/NCBI
|
|
12
|
Yang D, Du G, Xu A, Xi X and Li D:
Expression of miR-149-3p inhibits proliferation, migration and
invasion of bladder cancer by targeting S100A4. Am J Cancer Res.
7:2209–2219. 2017.PubMed/NCBI
|
|
13
|
Zabaglia LM, Bartolomeu NC, Dos Santos MP,
Peruquetti RL, Chen E, de Arruda Cardoso, Smith M, Payao SLM and
Rasmussen LT: Decreased MicroRNA miR-181c expression associated
with gastric cancer. J Gastrointest Cancer. 49:97–101. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Celano M, Rosignolo F, Maggisano V, Pecce
V, Iannone M, Russo D and Bulotta S: MicroRNAs as biomarkers in
thyroid carcinoma. Int J Genomics. 2017:64965702017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kang M, Shi J, Peng N and He S:
MicroRNA-211 promotes non-small-cell lung cancer proliferation and
invasion by targeting MxA. Onco Targets Ther. 10:5667–5675. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Tavazoie SF, Alarcon C, Oskarsson T, Padua
D, Wang Q, Bos PD, Gerald WL and Massague J: Endogenous human
microRNAs that suppress breast cancer metastasis. Nature.
451:147–152. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Cui F, Li X, Zhu X, Huang L, Huang Y, Mao
C, Yan Q, Zhu J, Zhao W and Shi H: MiR-125b inhibits tumor growth
and promotes apoptosis of cervical cancer cells by targeting
phosphoinositide 3-kinase catalytic subunit delta. Cell Physiol
Biochem. 30:1310–1318. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zuo QF, Zhang R, Li BS, Zhao YL, Zhuang Y,
Yu T, Gong L, Li S, Xiao B and Zou QM: MicroRNA-141 inhibits tumor
growth and metastasis in gastric cancer by directly targeting
transcriptional co-activator with PDZ-binding motif, TAZ. Cell
Death Dis. 6:e16232015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhao XQ, Liang B, Jiang K and Zhang HY:
Down-regulation of miR-655-3p predicts worse clinical outcome in
patients suffering from hepatocellular carcinoma. Eur Rev Med
Pharmacol Sci. 21:748–752. 2017.PubMed/NCBI
|
|
20
|
Wu G, Zheng K, Xia S, Wang Y, Meng X, Qin
X and Cheng Y: MicroRNA-655-3p functions as a tumor suppressor by
regulating ADAM10 and β-catenin pathway in hepatocellular
carcinoma. J Exp Clin Cancer Res. 35:892016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Lv ZD, Kong B, Liu XP, Jin LY, Dong Q, Li
FN and Wang HB: miR-655 suppresses epithelial-to-mesenchymal
transition by targeting Prrx1 in triple-negative breast cancer. J
Cell Mol Med. 20:864–873. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wang Y, Zang W, Du Y, Ma Y, Li M, Li P,
Chen X, Wang T, Dong Z and Zhao G: Mir-655 up-regulation suppresses
cell invasion by targeting pituitary tumor-transforming gene-1 in
esophageal squamous cell carcinoma. J Transl Med. 11:3012013.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Li J, Li C, Li H, Zhang T, Hao X, Chang J
and Xu Y: MicroRNA30a5p suppresses tumor cell proliferation of
human renal cancer via the MTDH/PTEN/AKT pathway. Int J Mol Med.
41:1021–1029. 2018.PubMed/NCBI
|
|
24
|
Li L and Zhang H: MicroRNA-379 inhibits
cell proliferation and invasion in glioma via targeting metadherin
and regulating PTEN/AKT pathway. Mol Med Rep. 17:4049–4056.
2018.PubMed/NCBI
|
|
25
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Xia X, Du R, Zhao L, Sun W and Wang X:
Expression of AEG-1 and microvessel density correlates with
metastasis and prognosis of oral squamous cell carcinoma. Hum
Pathol. 45:858–865. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Seyedmajidi M, Sohanian S, Abbaszadeh H,
Moslemi D and Bijani A: Astrocyte elevated gene 1 (AEG-1): A
promising candidate for molecular targeted therapy in oral squamous
cell carcinomas. Asian Pac J Cancer Prev. 18:3301–3305.
2017.PubMed/NCBI
|
|
28
|
Wang Y, Wang T, Sun Y, Sun W and Wang X:
Astrocyte elevated gene-1 promotes tumour growth and invasion by
inducing EMT in oral squamous cell carcinoma. Sci Rep. 7:154472017.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wang YP, Liu IJ, Chiang CP and Wu HC:
Astrocyte elevated gene-1 is associated with metastasis in head and
neck squamous cell carcinoma through p65 phosphorylation and
upregulation of MMP1. Mol Cancer. 12:1092013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Garzon R, Calin GA and Croce CM: MicroRNAs
in Cancer. Annu Rev Med. 60:167–179. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Garzon R and Marcucci G: Potential of
microRNAs for cancer diagnostics, prognostication and therapy. Curr
Opin Oncol. 24:655–659. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Schickel R, Boyerinas B, Park SM and Peter
ME: MicroRNAs: Key players in the immune system, differentiation,
tumorigenesis and cell death. Oncogene. 27:5959–5974. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Liang HQ, Wang RJ, Diao CF, Li JW, Su JL
and Zhang S: The PTTG1-targeting miRNAs miR-329, miR-300, miR-381
and miR-655 inhibit pituitary tumor cell tumorigenesis and are
involved in a p53/PTTG1 regulation feedback loop. Oncotarget.
6:29413–29427. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Kitamura K, Seike M, Okano T, Matsuda K,
Miyanaga A, Mizutani H, Noro R, Minegishi Y, Kubota K and Gemma A:
MiR-134/487b/655 cluster regulates TGF-beta-induced
epithelial-mesenchymal transition and drug resistance to gefitinib
by targeting MAGI2 in lung adenocarcinoma cells. Mol Cancer Ther.
13:444–453. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Su ZZ, Kang DC, Chen Y, Pekarskaya O, Chao
W, Volsky DJ and Fisher PB: Identification and cloning of human
astrocyte genes displaying elevated expression after infection with
HIV-1 or exposure to HIV-1 envelope glycoprotein by rapid
subtraction hybridization, RaSH. Oncogene. 21:3592–3602. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
He Z, He M, Wang C, Xu B, Tong L, He J,
Sun B, Wei L and Chu M: Prognostic significance of astrocyte
elevated gene-1 in human astrocytomas. Int J Clin Exp Pathol.
7:5038–5044. 2014.PubMed/NCBI
|
|
37
|
Li J, Zhang N, Song LB, Liao WT, Jiang LL,
Gong LY, Wu J, Yuan J, Zhang HZ, Zeng MS and Li M: Astrocyte
elevated gene-1 is a novel prognostic marker for breast cancer
progression and overall patient survival. Clin Cancer Res.
14:3319–3326. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Dong L, Qin S, Li Y, Zhao L, Dong S, Wang
Y, Zhang C and Han S: High expression of astrocyte elevated gene-1
is associated with clinical staging, metastasis and unfavorable
prognosis in gastric carcinoma. Tumour Biol. 36:2169–2178. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Nikpour M, Emadi-Baygi M, Fischer U,
Niegisch G, Schulz WA and Nikpour P: MTDH/AEG-1 contributes to
central features of the neoplastic phenotype in bladder cancer.
Urol Oncol. 32:670–677. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Yu JQ, Zhou Q, Zhu H, Zheng FY and Chen
ZW: Overexpression of astrocyte elevated gene-1 (AEG-1) in cervical
cancer and its correlation with angiogenesis. Asian Pac J Cancer
Prev. 16:2277–2281. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Alyasiri NS, Mehdi SJ, Alam MS, Ali A,
Mandal AK, Gupta S, Singh I and Rizvi MM: PTEN-mediated AKT
activation contributes to the reduced apoptosis among Indian oral
squamous cell carcinoma patients. J Cancer Res Clin Oncol.
138:103–109. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Gan YH and Zhang S: PTEN/AKT pathway
involved in histone deacetylases inhibitor induced cell growth
inhibition and apoptosis of oral squamous cell carcinoma cells.
Oral Oncol. 45:e150–e154. 2009. View Article : Google Scholar : PubMed/NCBI
|
